Xenetic Biosciences Inc

NASDAQ:XBIO 1:00:00 PM EDT

3.70

-0.24 (-6.09%)

4:32:08 PM EDT: $3.73 +0.03 (+0.81%)

Market Cap (Intraday)	5.71M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.64 Million
Adjusted EPS	-$0.64

See more estimates

10-Day MA	$3.59
50-Day MA	$3.08
200-Day MA	$3.63

See more pivots

Xenetic Biosciences Inc Stock, NASDAQ:XBIO

945 Concord Street, Suite 102, Framingham, Massachusetts 01701

United States of America

Phone: +1.781.778.7720

Number of Employees: 2

http://www.xeneticbio.com

Description

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patientÃ¢â?¬â?¢s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.